SEC Form 4 · accession 0001179110-19-002053
Axogen, Inc. · AXGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Erick Wayne DeVinney
Officer — VP, Clinical&Translational Sc
Period of report
Feb 15, 2019
Accepted (ET)
Feb 19, 2019 · 1:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000805928
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 15, 2019 | A | 5,079 | $0.00 | A | 43,469 | D | |
| Common StockF2 | Feb 15, 2019 | F | 1,498 | $17.57 | D | 41,971 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This reflects the number of shares that became vested as of February 15, 2019 upon the attainment of certain performance criteria.
- F2The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 15, 2019.